Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 03:06 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Missed Period Pill Study
NCT04940013 · University of California, San Francisco · PHASE4 · terminated · last registry update 2026-01-20 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Lack of successful recruitment and loss of funding” | – | Registry record, University of California, San Francisco |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER3 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-10-15Also stopped (terminated): University Hospital, Clermont-Ferrand, Oxytocin + Misoprostol Oral Tablet (NCT05568745)
- 2026-05-08Phase 3 first posted: Indiana University, Cervical ripening with a double balloon catheter plus misoprostol + Usual-care control group (NCT07576881)
- 2026-04-01Phase 3 first posted: University of Pennsylvania, 200mg mifepristone and 800mg misoprostol (NCT07506512)
- 2026-03-27Also stopped (terminated): Assistance Publique - Hôpitaux de Paris, Misoprostol (NCT01113229)
- 2026-03-18Results posted on the registry: Washington University School of Medicine, Mifepristone + Misoprostol (NCT05322252)
- 2026-02-24Phase 3 first posted: Udayana University, Bilateral ESPB: Ropivacaine 0.375% + Dexamethasone 5mg + Bilateral ESPB: Ropivacaine 0.375% (NCT07429708)
- 2026-01-26Also stopped (terminated): Baylor Research Institute, Pitocin (NCT02910115)
- 2025-11-17Results posted on the registry: Hackensack Meridian Health, Prophylactic use of ibuprofen and ondansetron post misoprostol administration + Use of ibuprofen and ondansetron at symptom onset post misoprostol administration (NCT05819619)
- 2025-11-17Also stopped (terminated): Hackensack Meridian Health, Prophylactic use of ibuprofen and ondansetron post misoprostol administration + Use of ibuprofen and ondansetron at symptom onset post misoprostol administration (NCT05819619)
- 2025-09-04Also stopped (withdrawn): Institut National de la Santé Et de la Recherche Médicale, France, Prostaglandin E2 (NCT00545194)
- 2025-08-24Results posted on the registry: Stanford University, Misoprostol 400mcg buccal + Placebo (NCT06078501)
- 2025-08-24Also stopped (terminated): Stanford University, Misoprostol 400mcg buccal + Placebo (NCT06078501)
- 2025-07-29Results posted on the registry: The University of Texas Health Science Center at San Antonio, Misoprostol 200Mcg Tab + Placebo (NCT03064568)
- 2025-06-06Also stopped (withdrawn): University of Chicago, a drug against PTGER3 (NCT06456164)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision